| Literature DB >> 16930665 |
Feng Li1, Dorian Zoumplis, Claudia Matallana, Nicole R Kilgore, Mary Reddick, Abdul S Yunus, Catherine S Adamson, Karl Salzwedel, David E Martin, Graham P Allaway, Eric O Freed, Carl T Wild.
Abstract
3-O-(3',3'-dimethylsuccinyl) betulinic acid, also termed PA-457 or DSB, is a novel HIV-1 inhibitor that blocks virus maturation by disrupting cleavage of the capsid precursor, CA-SP1. To better define the molecular target for PA-457, we prepared a panel of mutant viruses with point deletions spanning the CA-SP1 cleavage domain and characterized each of these viruses for PA-457 sensitivity. Our results indicate that amino acid residues in the N-terminal half of SP1 serve as determinants of PA-457 activity, while residues in the C-terminal half of SP1 were not involved in compound activity. These findings support and extend previous observations that PA-457 is a specific inhibitor of CA-SP1 cleavage and identify the CA-SP1 domain as the primary viral determinant for this novel inhibitor of HIV-1 replication.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16930665 DOI: 10.1016/j.virol.2006.07.023
Source DB: PubMed Journal: Virology ISSN: 0042-6822 Impact factor: 3.616